Pharmaceutical Technology on MSN
FDA approves MSD’s once-daily HIV combo Idvynso
GlobalData analysts forecast a blockbuster future for Idvynso, though they note it is unlikely it will displace market ...
Morning Overview on MSN
FDA approves Merck’s Idvynso combo pill for HIV treatment
The U.S. Food and Drug Administration on April 21, 2026, approved Merck’s Idvynso, a once-daily combination pill for HIV ...
(Reuters) -The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV treatments due to low levels of a type of white blood cell in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results